Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Rhythm Pharmaceuticals Inc banner

Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 84.295 USD -9.79%
Market Cap: $5.8B
Write Note Create Alert

Intrinsic Value

Is RYTM undervalued or overvalued?

See the intrinsic value estimate for Rhythm Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RYTM Intrinsic Value
LOCKED
Unlock
Today vs. history

RYTM looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with RYTM’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RYTM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $84.3
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RYTM

Fundamental Analysis

What Rhythm Pharmaceuticals Does

Biotechnology Health Care

Rhythm Pharmaceuticals is a biopharmaceutical company that focuses on rare genetic diseases that cause severe obesity. Its main product is Imcivree, a prescription medicine used for certain patients whose body’s appetite-control pathway does not work properly. The company also develops follow-on treatments aimed at the same biology, especially the melanocortin-4 receptor pathway that helps regulate hunger and body weight.

Headquarters
United States of America US
Employees
414
IPO date
Oct 5, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Rhythm Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

RYTM Insider Trading
Buy and sell transactions by insiders

Continue RYTM Research

Summary
RYTM intrinsic value, competitors valuation, and company profile.
DCF Valuation
RYTM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RYTM stock valuation using valuation multiples.
Wall St Estimates
RYTM price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RYTM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Rhythm Pharmaceuticals Inc listings:
F • EUR
1RV
 SWB • EUR
1RV
Discover More
What is the Intrinsic Value of one RYTM stock?

The intrinsic value for Rhythm Pharmaceuticals Inc (RYTM) under the Base Case is hidden USD.

Is RYTM stock undervalued or overvalued?

Compared with the current market price of 84.295 USD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.